Allogeneic Stem Cell Transplantation of CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients with Hemoglobinopathies
Latest Information Update: 27 Jun 2019
Price :
$35 *
At a glance
- Drugs Omidubicel (Primary)
- Indications Sickle cell anaemia; Thalassaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Gamida-Cell
- 16 Dec 2018 Status changed from recruiting to discontinued due to lack of recruitment
- 03 Jan 2018 Planned End Date changed from 1 Sep 2018 to 1 Dec 2019.
- 03 Jan 2018 Planned primary completion date changed from 1 Sep 2017 to 31 Dec 2018.